Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.24
-0.32 (-3.74%)
At close: Aug 28, 2025, 4:00 PM
8.24
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:11 PM EDT
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $444.10 million as of August 28, 2025. Its market cap has decreased by -58.96% in one year.
Market Cap
444.10M
Enterprise Value
93.21M
1-Year Change
-58.96%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $444.10M, an increase of 248.86%. That is a compound annual growth rate of 10.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 460.80M | -38.17% |
Dec 31, 2024 | 745.30M | -61.78% |
Dec 29, 2023 | 1.95B | -33.09% |
Dec 30, 2022 | 2.91B | 26.63% |
Dec 31, 2021 | 2.30B | 380.02% |
Dec 31, 2020 | 479.50M | -24.08% |
Dec 31, 2019 | 631.60M | 53.82% |
Dec 31, 2018 | 410.60M | -71.51% |
Dec 29, 2017 | 1.44B | -15.04% |
Dec 30, 2016 | 1.70B | -20.98% |
Dec 31, 2015 | 2.15B | 277.66% |
Dec 31, 2014 | 568.50M | -1.92% |
Dec 31, 2013 | 579.60M | 347.22% |
Dec 31, 2012 | 129.60M | 1.81% |
Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 658.49B |
Johnson & Johnson | 422.42B |
AbbVie | 365.68B |
UnitedHealth Group | 272.61B |
AstraZeneca | 248.07B |
Novo Nordisk | 246.45B |
Novartis AG | 245.68B |
Abbott Laboratories | 227.41B |